German research institute BioMed X and Ono Pharmaceutical, a Japanese pharmaceutical company, started a new joint research project on cancer immunotherapies. HEIDELBERG, GERMANY / ACCESSWIRE / ...
Nico Frisch brings strong administrative and operational experience from the Max Planck Institute for Medical Research to the BioMed X Heidelberg Institute. Nico Frisch is an administration and ...
BioMed X announced the launch of a pilot initiative with Harvard University under BioMed X’s XBridge framework to support structured research collaborations between academic investigators and ...
BioMed X is an independent research institute with sites in Heidelberg, Germany, New Haven, Connecticut, XSeed Labs in Ridgefield, Connecticut, and a worldwide network of partner locations. We operate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results